Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 5 | $2,422 |
Sells | 1334 | $474,117,098 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
03 Apr 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 01 Apr 2024 | Sale | 5,005 | 228.3399 | 1,142,841 | D |
13 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 11 Mar 2024 | Sale | 4,580 | 249.7572 | 1,143,888 | D |
09 Jan 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 06 Jan 2023 | Sale | 4,148 | 276.31 | 1,146,134 | D |
29 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 27 Mar 2024 | Sale | 4,748 | 242.3804 | 1,150,822 | D |
01 Dec 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 29 Nov 2022 | Sale | 4,263 | 270.3075 | 1,152,321 | D |
19 Jan 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 19 Jan 2023 | Sale | 4,500 | 259.021 | 1,165,594 | D |
28 Jun 2022 16:37 | UTHR | UNITED THERAPEUTICS Corp | CAUSEY CHRISTOPHER | Director | 27 Jun 2022 | Sale | 5,000 | 236.79 | 1,183,950 | D |
03 Apr 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 02 Apr 2024 | Sale | 5,216 | 228.8146 | 1,193,497 | D |
27 Dec 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 23 Dec 2022 | Sale | 4,368 | 277.4181 | 1,211,762 | D |
03 Apr 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 01 Apr 2024 | Sale | 5,354 | 229.3773 | 1,228,086 | D |
07 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 06 Mar 2024 | Sale | 5,219 | 236.7699 | 1,235,702 | D |
25 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 22 Mar 2024 | Sale | 5,212 | 237.56 | 1,238,163 | D |
05 Apr 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 04 Apr 2024 | Sale | 5,323 | 232.8428 | 1,239,422 | D |
11 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 08 Mar 2024 | Sale | 5,139 | 243.378 | 1,250,720 | D |
19 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 18 Mar 2024 | Sale | 5,574 | 234.3115 | 1,306,052 | D |
05 Mar 2024 16:33 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 01 Mar 2024 | Sale | 5,773 | 232.0355 | 1,339,541 | D |
24 Apr 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 20 Apr 2023 | Sale | 6,099 | 224.9367 | 1,371,889 | D |
19 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 15 Mar 2024 | Sale | 5,789 | 237.5755 | 1,375,325 | D |
03 Jan 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | PRESIDENT AND COO | 29 Dec 2022 | Sale | 5,000 | 275.99 | 1,379,950 | D |
11 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 08 Mar 2024 | Sale | 5,783 | 242.23 | 1,400,816 | D |
07 Dec 2023 16:30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP & GENERAL COUNSEL | 07 Dec 2023 | Sale | 5,900 | 238.8751 | 1,409,363 | D |
15 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 14 Mar 2024 | Sale | 5,955 | 237.6187 | 1,415,019 | D |
21 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 20 Mar 2024 | Sale | 6,055 | 236.3707 | 1,431,225 | D |
06 May 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | OLIAN JUDY D. | Director | 03 May 2024 | Sale | 5,616 | 258.895 | 1,453,954 | D |
27 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 26 Mar 2024 | Sale | 5,926 | 247.633 | 1,467,473 | D |
11 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 07 Mar 2024 | Sale | 6,223 | 240.2882 | 1,495,313 | D |
19 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 18 Mar 2024 | Sale | 6,627 | 235.0471 | 1,557,657 | D |
11 Apr 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 09 Apr 2024 | Sale | 6,994 | 236.7448 | 1,655,793 | D |
29 Nov 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 28 Nov 2022 | Sale | 6,320 | 269.9573 | 1,706,130 | D |
05 Apr 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 04 Apr 2024 | Sale | 7,478 | 233.8805 | 1,748,958 | D |
13 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 12 Mar 2024 | Sale | 7,091 | 247.2014 | 1,752,905 | D |
05 Apr 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 03 Apr 2024 | Sale | 8,039 | 230.9742 | 1,856,802 | D |
03 Apr 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 02 Apr 2024 | Sale | 8,121 | 229.6387 | 1,864,896 | D |
11 Apr 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 09 Apr 2024 | Sale | 8,006 | 237.5172 | 1,901,563 | D |
25 Mar 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 21 Mar 2024 | Sale | 8,650 | 236.5719 | 2,046,347 | D |
28 Jun 2022 16:30 | UTHR | UNITED THERAPEUTICS Corp | OLIAN JUDY D. | Director | 27 Jun 2022 | Sale | 9,300 | 240.2944 | 2,234,738 | D |
11 Apr 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 10 Apr 2024 | Sale | 9,940 | 237.5188 | 2,360,937 | D |
16 May 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND TREASURER | 15 May 2024 | Sale | 15,160 | 272.69 | 4,133,980 | D |
16 May 2024 16:30 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | CFO AND TREASURER | 15 May 2024 | Sale | 25,000 | 272.69 | 6,817,250 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)